Trademarkia Logo

Canada

C$
Trademark Search in Canada
INREBIC & Geometric V Design (black & white; Version 2)

View On IC.GC.CA

INREBIC & Geometric V Design (black & white; Version 2)
APPROVED

on 5 May 2025

Last Applicant/ Owned by

Impact Biomedicines, Inc.

86 Morris AvenueSummit, NJ 07901

US

Serial Number

2254142 filed on 26th Apr 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

INREBIC & Geometric V Design (black & white; Version 2)

Trademark usage description

pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, bloo Read More

Vienna Information

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

25 . 12 . 25

Surfaces or backgrounds covered with any other ornamentSurfaces ou fonds couverts d'un autre ornement

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 3

Surfaces or backgrounds covered with squares or rectangles (except a 25.7.4)Surfaces ou fonds couverts de carrés ou de rectangles (excepté a 25.7.4)

26 . 15 . 13

PrismsPrismes

26 . 15 . 25

Other geometrical solidsAutres corps géométriques

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer, beta thalassemia and myelodysplastic syndromes, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, hematological tumors and blood tumors

Classification kind code

12

Mark Details

Serial Number

2254142

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 5th May 2025		Approved
Submitted for opposition 27
on 5th May 2025		Approval Notice Sent
Submitted for opposition 22
on 27th Nov 2024		Search Recorded
Submitted for opposition 20
on 27th Nov 2024		Examiner's First Report
Submitted for opposition 287
on 11th May 2023		Pre-Assessment Letter Sent
Submitted for opposition 30
on 26th Apr 2023		Filed
Submitted for opposition 1
on 26th Apr 2023		Created
Submitted for opposition 31
on 26th Apr 2023		Formalized